Table 3 HOMA-IR and HOMA-%B at study inception and conclusion in treated and control subjects
From: Correction of metabolic acidosis improves insulin resistance in chronic kidney disease
Treated | Control | P value (between group) | |
|---|---|---|---|
HOMA-IR | |||
Baseline | 6.4 [5.5–7.9] | 6.4 [5.5–8.2] | 0.915 |
Study Completion | 5.9 [5.0–7.0] | 6.3 [5.3–8.2] | 0.010 |
P-value (within group) | 0.004 | 0.572 | |
HOMA-%B | |||
Baseline | 50.5 [32.0–67.2] | 43.0 [32.7–62.2] | 0.543 |
Study Completion | 60.5 [43.5–70.2] | 45.0 [32.7–64.5] | 0.023 |
P-value (within group) | 0.036 | 0.754 | |